Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | CCR1 | P32246 | 1/20 | 0.30 |
| ▸ | CCR5 | P51681 | 1/20 | 0.30 |
| ▸ | CCR8 | P51685 | 1/20 | 0.30 |
| ▸ | METAP1 | P53582 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.30 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30008586 | 0.76 | L3MBTL1 (0.35) | KDM4ELMNACYP1A2POLBCCR1 | |
| SCHEMBL11545311 | 0.74 | LMNA (0.33) | MMP2MMP9KDM4ELMNAALDH1A1 | |
| SCHEMBL1692391 | 0.66 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL13330642 | 0.66 | SLC6A2 (0.33) | KDM4ELMNACYP1A2POLBCCR1 | |
| SCHEMBL18572160 | 0.63 | CA12 (0.38) | — | |
| SCHEMBL13330631 | 0.62 | OPRL1 (0.37) | KDM4E | |
| SCHEMBL10694098 | 0.62 | FDPS (0.34) | — | |
| SCHEMBL8237320 | 0.62 | HTR2C (0.41) | CYP1A2ALDH1A1 | |
| SCHEMBL2125224 | 0.61 | GAA (0.43) | MMP2MMP9KDM4ELMNAALDH1A1 | |
| SCHEMBL31425525 | 0.61 | NOS3 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100121065-A1 | Phosphors with High Luminous Efficiency and Display Device Containing Them | GRACEL DISPLAY INC. (KR) | 2010-05-13 | — | — | US | disclosed |
| US-20100121065-A1 | Phosphors with High Luminous Efficiency and Display Device Containing Them | GRACEL DISPLAY INC. (KR) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100121065-A1 | Phosphors with High Luminous Efficiency and Display Device Containing Them | PPIP5K2, ACP1, INPP5B | MMP2 4701/4885MMP9 4750/4885KDM4E 3497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.